Unconfigured Ad

Collapse
X
Collapse
 
  • Page of 1
  • Filter
  • Time
  • Show
Clear All
new posts
Previous template Next
  • bearstillfar
    Junior Member
    • May 2014
    • 1
    #1

    Hi

    Hi, everyone.

    I'm Bear and I'm a biochemist in China.

    I'll be using MiSeq in the near future and I'm not very experienced especially the data mining.

    I wish to learn more here, figured to say hi first.

    Cheers
    Tags: None
  • Jane_Su
    Junior Member
    • May 2014
    • 1
    #2
    Aslo from China.just say hello...

    Comment

    Previous template Next

    Latest Articles

    Collapse
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM
    View All

    ad_right_rmr

    Collapse

    News

    Collapse
    Topics Statistics Last Post
    Study Captures the First Moments of DNA Replication by SEQadmin2
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    29 views
    0 reactions
    		 Last Post SEQadmin2
    by SEQadmin2
    07-24-2026, 12:17 PM  
    Chemotherapy Leaves Detectable DNA Signatures in Childhood Tumors by SEQadmin2
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    21 views
    0 reactions
    		 Last Post SEQadmin2
    by SEQadmin2
    07-23-2026, 11:41 AM  
    Single-Cell Atlases Skew Toward European Ancestry, Analysis Finds by SEQadmin2
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    212 views
    0 reactions
    		 Last Post SEQadmin2
    by SEQadmin2
    07-20-2026, 11:10 AM  
    UC San Diego Bioengineers Map Gene Function in Human Stem Cells by SEQadmin2
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    78 views
    0 reactions
    		 Last Post SEQadmin2
    by SEQadmin2
    07-13-2026, 10:26 AM  
    View All
    Working...